The genomic basis of the Williams – Beuren syndrome by unknown
Review
The genomic basis of the Williams – Beuren syndrome
C. Schubert
Institute of Human Genetics, Georg-August-University of Goettingen, Heinrich-Dueker-Weg 12,
37073 Goettingen (Germany), Fax: +49-551-39 7567, e-mail: cschube@gwdg.de
Received 11 July 2008; received after revision 15 October 2008; accepted 16 October 2008
Online First 26 November 2008
Abstract.TheWilliams-Beuren syndrome is a genomic
disorder (prevalence: 1/7,500 to 1/20,000), caused by a
hemizygous contiguous gene deletion on chromosome
7q11.23. Typical symptoms comprise supravalvular
aortic stenosis, mental retardation, overfriendliness
and visuospatial impairment. The common deletion
sizes range of 1.5–1.8 mega base pairs (Mb), encom-
passing app. 28 genes. For a few genes, a genotype-
phenotype correlation has been established. The best-
explored gene within this region is the elastin gene; its
haploinsufficiency causes arterial stenosis. The region
of the Williams-Beuren syndrome consists of a single
copy gene region (~1.2 Mb) flanked by repetitive
sequences – Low Copy Repeats (LCR). The deletions
arise as a consequence of misalignment of these
repetitive sequences during meiosis and a following
unequal crossing over due to high similarity of LCRs.
This review presents an overview of the Williams-
Beuren syndrome region considering the genomic
assembly, chromosomal rearrangements and their
mechanisms (i.e. deletions, duplications, inversions)
and evolutionary and historical aspects.
Keywords.Williams-Beuren syndrome, non-allelic homologous recombination, deletion, duplication, 7q11.23,
elastin gene, supravalvular aortic stenosis, LCR.
Introduction
Clinical symptoms. The Williams-Beuren syndrome
(WBS) is a rare genomic disorder (1/7,500 – 1/20,000)
caused by a hemizygous deletion of contiguous genes
on chromosome 7q11.23 [1]. It was first described in
the nineteen-fifties by Fanconi, Lightwood and Payne
as “Idiopathic infantile hypercalcaemia with failure to
thrive” [2–4]. WBS patients clinically display a
characteristic pattern of symptoms including vascular
stenosis (predominantly supravalvular aortic stenosis
(SVAS)), weakness of connective tissue, a typical face,
short stature and mental retardation [5–7]. Facial
symptoms include a wide mouth with full cheeks and
full lips and periorbital fullness with a broad forehead.
The cardiovascular manifestations comprise SVAS
and peripheral artery stenosis, which occur in 75% of
affected children [8]. Developmental delay is distinct
in tasks requiring complex visual analysis for receiving
information, whereasWBS patients perform better on
tasks with auditory input and verbal output [9]. The
typical behavioural features such as poor social
relationships, overfriendliness, high sociability and
empathy persist usually from childhood to adulthood
[10–12]. There is a clear weakness in daily living skills
andmotor abilities in patients withWBS [13–15]. The
IQ range varies from severe mental retardation to a
nearly normal level (mean value 57) and attention
deficit hyperactivity disorder (ADHD) is common
[16]. Typical cranial abnormalities are not frequent in
WBS patients except for an unspecific decreased
parieto-occipital lobe volume [17, 18]. Additional
universal clinical symptoms are intermittent hyper-
calcaemia, hypertonia, renal anomalies, dental prob-
lems (malocclusion), scoliosis/kyphosis, and joint
limitation [19, 20]. Studies on monozygotic twins
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suffering from WBS revealed that most clinical signs,
i.e. cardiac defects and abnormal behavioural features
are concordant, whereas birth weight, stature and
grade ofmental retardation seem to be influenced also
by environmental factors [21].
Adults with WBS suffer predominantly from the
consequences of cardiac defects and hypertension,
sensorineural hearing loss, subclinical hypothyroid-
ism, gastrointestinal problems and urinary tract ab-
normalities. Progressive joint limitation affects coor-
dination and motor skills [12, 16, 22]. Furthermore, a
high frequency of psychiatric symptoms, such as
anxiety and depression, are noticeable. Independent
living and employment are limited by their mental
handicap and by their physical problems [16, 23–25].
The history of the Williams-Beuren syndrome
The genetic cause of WBS remained unclear until the
nineteen-nineties. At the beginning, several unbal-
anced chromosomal anomalies, not involving chro-
mosome 7, have been identified in WBS-affected
children, andweremisleadingly suspected to cause the
disease [26–28]. A first hint of the genetic basis of
WBS was given by the identification of the elastin
gene (ELN) in 1993 in a case of familial SVAS
segregating with a reciprocal translocation involving
chromosomes 6 and 7, which disrupted the ELN gene
[29]. This gene was mapped to chromosome 7q11.2
two years before in 1991 [29]. Based on the phenotypic
similarity between SVAS and WBS, it was hypothe-
sized that haploinsufficiency for ELN was also the
cause of WBS and deletion of ELN was subsequently
demonstrated [29, 31–35]. Several studies that fol-
lowed confirmed and consolidated the previous find-
ings of hemizygousity of the ELN gene as a major
cause of WBS. Fluorescence in-situ hybridisation
(FISH) analysis with probes for the elastin locus
emerged to become the standard method for WBS
diagnosis [36–40]. A number of subsequent analyses
based on microsatellite DNA markers supported the
former hypothesis of a contiguous gene disorder in
patients with WBS. PCR-based genotyping of several
microsatellite markers around the elastin locus re-
vealed an extended deletion size of several hundred
kilo base pairs (kb) [41]. The DNA marker D7S489,
located near the ELN gene, shows a high homology to
other loci related to the deletion region, therefore it
was suspected that repetitive sequences flanking the
deletion region could play a role in the mutational
mechanism of WBS [42]. An initial physical map of
the telomeric part of the WBS region (of ~500 kb in
size) encompassed the genesELN,LIMK1, RFC2 and
other putative transcripts (WBSCR (Williams-Beuren
Syndrome Chromosomal Region) 1–5), which are
commonly deleted in patients with WBS [43–46]. In
an effort to discover genes whose haploinsufficiency
may explain the diversified phenotype of WBS and to
determine the deletion size of the WBS locus,
numerous studies of gene identifications were pub-
lished in the second period of the nineteen-nineties
[12, 47–77]. The physical map of the WBS deletion
locus became more and more complete (Table 1).
Genomic rearrangements and mutational
mechanisms in WBS
Deletions. To date twenty-eight coding genes have
been identifiedwithin theWBSdeletion region, which
is composed of a single copy gene region of ~1.2Mb in
size flanked by three large low-copy-repeat sequences
(LCR), arranged in LCR blocks A, B and C. These
blocks are ordered in complexes, which are located on
the centromeric (cen), the medial (mid) and on the
telomeric (tel) part of the WBS locus (A-B-C cen, A-
B-C mid and A-B-C tel). Each of these complexes,
consisting of one of each block, has a size of
approximately 320 kb. Common deletions in WBS
patients span a genomic region of around ~1.5 Mb
with suspected breakpoints within the centromeric
and medial LCR block B [72–78] (Figs. 1 and 2).
Deletions occur regardless of the parental origin of the
disease-transmitting chromosome; furthermore, there
is no support for imprinted genes within the common
deletion region [42, 62, 72, 73, 78–83]. Usually, WBS
occurs sporadically, but a few cases of autosomal
dominant inheritance have been reported. In these
described families the disease-transmitting parent
presented only a mild or oligosymptomatic pattern
of WBS [84–87]. However, in some case-reports the
clinical diagnosis of autosomal dominant inheritance
ofWBSwas assumed based only on the fact of familial
accumulation of WBS symptoms and was not con-
firmed by cytogenetic analysis [85, 86].
Atypical deletions with smaller and larger deletion-
sizes have also been reported. According to the
literature, about 5% of typical WBS-patients display
a deletion of ~1.8 Mb, which is caused by recombina-
tion between the centromeric and medial LCR block
A copies [72, 73, 78, 88, 89]. Furthermore, there are
many reports on patients displaying deletions of
partial sizes with breakpoints within the single copy
region of the WBS. The detected deletion sizes range
between 0.1Mb – 1Mb. The phenotypes presenting by
these patients vary between isolated SVAS in small
deletions including only the ELN gene and the full
spectrum of WBS in deletion sizes of up to 1 Mb [43,
89–96]. It seems that partial deletions encompassing
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Table 1.
Summary of single genes within the WBS region. Displayed are the gene name, chromosomal positions, transcription direction and gene
type. In addition, a selection of known STS-markers within this region is depicted in the right column. Furthermore, the right column
displays in grey positions the different PCR-amplicons (Ampl.qPCR) used in the deletion screening in Schubert C et al. 2006 [97].
Information derived from the Build 36.3 National Center for Biotechnology Information. In this assembly, a gap exists of ~250 Kb (Chr. 7:
74,350 Kb to 74,600 K) with no information about genomic organisation of this region. Beside the table, in vertical arrows, the common
deletion size of ~1.5 Mb and the more rare deletion size of ~1.8 Mb in WBS patients are depicted. In the common deletions, breakpoints
occur within the LCR block B, in the case with a larger deletion a recombination occurs within the LCR blocks A cen and A mid. These
NAHR events affect 26 coding genes that are invariably deleted. In addition to these 26 genes, NCF1 and GTF2IRD2 can be variable
deleted depending on theNAHR locus within blockB or –A. Larger and smaller atypical deletion sizes in patients with the full or a partial
clinical spectrum have also been described (not displayed in the picture, for more information see text passage).
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the telomeric part of WBS region distal to the ELN
gene cause a more severe phenotype than partial
deletions, which encompass the part centromeric to
the ELN gene [43, 93–95]. In our qPCR-analysis of
patients with the clinical suspicion of WBS, the
deletion-sizes range between ~0.2 Mb to ~2.5 Mb,
whereas 90% of deletion-positive patients carry a
deletion in the range from 1.4 to 1.9Mb. It is suggested
that patients with a deletion size of ~1.4 to ~1.6 Mb
display the deletion breakpoints within the LCR
blocks B cen and B med, whereas the breakpoints of
a deletion size of ~1.7 to ~1.9 Mb are within the
centromer and medial LCR block A [78, 97] (Fig. 1,
Table 1).
The deletions in the WBS region arise as a conse-
quence of misalignment of gametes during meiosis
following unequal crossing over (NAHR – non-allelic
homologous recombination) due to high similarity of
LCR blocks, especially block B (Fig. 3A and B).
About 5% of the entire human genome contains
LCRs with a relatively large size (> 10 kb) and with
high sequence identity (> 95%) [98]. It is suggested
that regions of high sequence identity are required to
facilitate NAHR and that a certain length of perfectly
matched sequences is necessary for efficient NAHR
[99–101]. Interchromosomal or interchromatid re-
combination of misplaced aligned chromosomal re-
gions (different LCR blocks) with high sequence
identity and the same orientation will lead to a
deletion and a reciprocal duplication of the genomic
region located between the repeated regions
(Fig. 3A). Intrachromatid NAHR generates a dele-
tion and a reciprocal circular acentric chromosome
(Fig. 3B). It is assumed that the highest rates of
NAHR occur at repeats with a close distance and high
similarity [101–103]. Haplotype analyses in families
with an affected child with WBS revealed that two-
thirds of the cases the chromosomal misalignment
seems to result from interchromosomal reshuffling
between homologous chromosomes 7 and in one-third
of cases from an intrachromosomal (inter- or intra-
chromatid) rearrangement between sister chromatids
[79, 80, 82]. Breakpoint-specific sequencing of the
WBS region in sperm revealed that interchromatid
recombination is much less frequent than intrachro-
matid or interchromosomal recombination. Investi-
gation of sperm samples for deletion- and duplication
rates in theWBS locus revealed a deletion rate of ~ 1 x
Table 1. (continued)
Figure 1. Graphical view of the Williams-Beuren-Deletion region
on chromosome 7q11.23. The location and orientation of the low-
copy-repeat (LCR) blocks A-C are depicted in arrows. The base
pairs positions (bp) are predicted on Build 36.3, National Center
for Biotechnology Information. Underneath the relative density of
Alu-repeats in the sectionofLCR, blocks are shown.Ahighdensity
ofAlu-repeats is present at the outer edges of the blocks, indicating
Alu-mediated rearrangements during evolutionary development
of the WBS region. The horizontal arrows display the common
deletion sizes of ~1.5 Mb and ~1.8MBwith breakpoints within the
centromeric and the medial copy of LCR block B and within the
centromeric and themedial copy of LCRblockA, respectively. *In
the current assemblies of the human genome, a gap exists of ~250
Kb (Chr. 7: 74,350 Kb to 74,600 Kb) with no information about the
genomic organisation of this region
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10–5 and a duplication rate of 5 x 10–6, leading to a
deletion-duplication rate of 2:1. The higher deletion
frequency could be explained by the high rate of
intrachromatid recombination leading to a deletion
and a reciprocal acentric chromosome, but not to a
duplication of the WBS region. This germline-related
deletion rate encompasses the disease-based estimat-
ed prevalence of WBS of 1/7,500 to 1/25,000. It has to
be mentioned that in this assay only one specific
sequence within the LCR block B has been used for
recombination studies. Several recombination hot
spots have been identified within the blocks B and
A, the deletion/duplication rates at these sites may be
different [103].
Breakpoint studies in patients carrying a ~1.5 Mb
deletion revealed that the majority of samples dis-
played breakpoints within the genesGTF2IP1 (B cen)
and GTF2I (B mid), whereas some cases presented
breakpoints in the genesNCF1B (B cen) andNCF1 (B
mid) and several cases within the genes GTFIRD2P
(B cen) and GTFIRD2 (B mid). The authors of this
study assume that the high sequence homology of the
blocks B cen and B mid predisposes for non-allelic
homologous recombination. The overall sequence
identity of B cen and B mid is 99.6%, in contrast to
a sequence identity of 98.2% between blocks A cen
and Amid with two large deletions of 15 kb and 26 kb
in block A mid. Furthermore, the interval size
between blocks B cen and B mid is shorter (~1.5
Mb) than between the block A cen and A mid (~1.8
Mb). This reduced interval size is also suspected to
promote rearrangements involving predominantly
blocks B cen and B mid [78] (Figs. 1 and 2).
Inversions. In the population of WBS patients, about
30% of the chromosome-transmitting parents are
Figure 2. Graphic of the centromeric and telomeric genomic region of LCR blocks of the WBS locus: Displayed are the single genes in
their position in megabases (Mb) on chromosome 7 and their orientation within theWBS region. The genes comprised to one LCR-block
are indicatedwith colored arrows underneath: red: LCRblocksA, blue: LCRblocksB, green: LCRblocksC. The base pairs positions (bp)
are predicted onBuild 36.3National Center forBiotechnology Information http://www.ncbi.nlm.nih.gov. and assemblyMarch 2006 byThe
UCSC Genome Browser Database http://genome.ucsc.edu/index.html ). *In the current assemblies of the human genome, a gap exists of
~250 Kb (Chr. 7: 74,350 Kb to 74,600 Kb) with no information about the genomic organisation of this region.
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carriers of a paracentric inversion of theWBS locus on
chromosome 7 with breakpoints external to the WBS
single copy gene region, which does not disrupt any
actively expressed genes [78, 104]. In the non-WBS
population, this inversion is present in about 5% [104,
105]. The inversion is generated by meiotic or mitotic
intrachromatid misalignment between the inverted
homologous centromeric and telomeric LCR blocks,
resulting in a non-allelic homologous recombination
between the pairedLCRblocks. This can occur in each
of the LCR blocks, resulting in a variable sized
paracentric inversion (1.8 – 2.9 Mb) [78, 104–107]
(Fig. 4A).
Presence of this inversion predisposes to chromoso-
mal mispairing in meiosis. An interchromosomal or
interchromatidNAHRevent between an inverted and
a non-inverted chromosome would result in a deletion
and a reciprocal duplication of the WBS region
(Fig. 4B). In contrast, in NAHR under participation
of an inverted chromosome the sizes of perfect
matched sequences is increased due to twomisaligned
LCR blocks instead of only one LCR block in
chromosome pairing of two non-inverted chromo-
somes (Fig. 3A and 4B).
Additionally, Bayes and co-workers created a differ-
ent model for the occurrence of a WBS deletion by
chromosomal mispairing of an inverted and a non-
inverted chromosome. Thereafter (analogous to the
typical loop-formation of chromosomes with para-
centric inversions during chromosomal pairing) a
pairing of an inverted and a non-inverted WBS-
chromosome would produce a loop of the single-copy
gene region of WBS and a misalignment of LCR
blocks. A deletion or a reciprocal duplication of the
WBS region would occur, if an unequal crossing-over
arise between the misaligned blocks B tel and B mid,
derived either from the inverted chromosome or from
the non-inverted chromosome. A crossing over within
the loop of the single-copy region of the WBS region
would result in either an acentric or a dicentric
chromosome 7 with high risk for fetal loss [78]
(Fig. 4C).
On a formal genetic basis the recurrence risk of a
WBS-inversion carrier for a child withWBS is up to 1 :
500, due to a recombination rate of up to 0.2% in the
non-allelic misaligned fragments (two LCR blocks
each with a size of ~100 kb corresponding to a region
specific recombination rate of 0.3–1% per 1 Mb) [78,
103, 106]. An inhibited formation of chiasmata during
meiosis because of the inverted WBS region could
further raise the risk of misalignment between non-
allelic LCR blocks; thus, individuals carrying the
inversion are of higher susceptibility to deletion or
duplication during meiosis [101, 107].
The presence of this inversion has also been reported
for patients displaying symptoms of WBS [104].
However, in a recent study on expression level of
genes within the WBS single-copy region revealed no
significant differences in gene expression level be-
tween individuals without the inversion and healthy
inversion-carriers, except for a 1.2-fold elevated
STX1A expression in inversion carrier. This suggests
that the inversion of theWBS region should not cause
clinical symptoms [108].
Duplication. Recently, some case reports described
several patients with a duplication of theWBS region,
who display as a pathognomonic feature a severe
expressive-language delay. In some cases, behavioural
abnormalities such as ADHD (Attention Deficit
Hyperactivity Disorder) or autism are present. Only
mild, not apparently specific anomalies in cranialMRI
Figure 3. (A) Interchromosomal or interchromatid NAHR be-
tween theLCRblockBmid fromone chromosomeand blockB cen
from the sister-chromosome or -chromatid. Unequal crossing over
results in a deletion and a reciprocal duplication of theWBS region
with creation of a fusion of LCR block B cen and B mid. (B)
Intrachromatid NAHR between the LCR blocks B mid and B cen
from the same chromatid. Unequal crossing over results in a
deletion of theWBS region with creation of a fusion of LCR block
B cen and B mid and a reciprocal acentric chromosome with high
risk for segregation loss.
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(magnetic resonance imaging) and EEG (electro-
encephalography) are recognizable. No pathogno-
monic facial dysmorphism seems to be associated with
this chromosomal rearrangements, but in some cases
synostosis or trigonocephaly with a broad nose,
posterior rotated ears, high arched palate and short
philtrum are manifest [109–118]. In a third of cases,
the duplication is inherited from one parent; in a few
of the reported families, the chromosome-transmit-
ting parent displayed a mild pattern of WBS-duplica-
tion typical symptoms. This observation of only minor
symptoms in the duplication-carrying parent could
imply that, in addition to gene dosage effects, other
mechanisms such as genetic and/or environmental
interactions are important in determining the pheno-
typic outcome of patients with this genetic aberration
[109, 111, 116, 118]. Using FISH and quantitative real
time PCR, the size of the duplication was calculated
generally to be the same size as of the common
deletion region in WBS (~1.5 Mb). The breakpoints
occur within the LCR blocks B cen and Bmid with an
increased expression of the genes within the single
copy region of WBS [110, 111]. Smaller and larger
duplication sizes have also been reported [111, 117,
118]. Duplications within the WBS region are sup-
posed to result from the same mechanism of unequal
meiotic recombination as the occurrence of deletions
in this region. It has been shown that duplications of
the WBS region arise at half the frequency as
deletions. So far, only a few cases of duplications
have been described in the literature. The clinical
presentation associated with reciprocal WBS duplica-
tions certainly seems to be milder, and facial features
are different and less distinct than those ofWBS; thus,
presumably more patients exist but remain undiag-
nosed [103, 110, 118, 119].
Evolution of the Williams-Beuren syndrome region
It is assumed that the origin of the segmental
duplications (LCRs) in the WBS region developed
~25Mya (million years ago) after the separation of the
macaque from the homonidae [76, 120]. The common
ancestral chromosome of 7q11.23 in macaque differs
only marginally from the syntenic region in mouse.
The divergence of rodents and primates is estimated at
~80 Mya ago, demonstrating the absence of large
chromosomal rearrangements in this period. It has
been shown that the human LCR blocks are absent in
mouse. The orthologous genes are single loci mapped
on mouse chromosome 5G1. The order of intradele-
tion located genes relative to extradeletion loci is
inverted with respect to the human genome map [73,
76, 88, 120, 121].
The ancestral chromosome present in the macaque
line consists of the blocks B and C flanking the entire
coding region of WBS. After divergence of the
homonidae from the macaque species a first para-
centric inversion between 7q11 and 7q22 occurred
with breakpoints at the outer edges of the blocks B
and C next to the formation of block A by a
duplication of an ancestral gene (STAG3) in 7q22
[122]. Block A (in the human genome the telomeric
LCR block A) was oppositely oriented to the primor-
Figure 4. (A) Development of an inversion in theWBS region due
to an intrachromatid misalignment of inverted LCR blocks, which
leads to an inversion of the WBS region with breakpoints within
this block, where the unequal crossover has occurred. In the
depiction, a crossover in the B block is illustrated. (B) NAHR
between two misaligned blocks B located either on an inverted
chromosome or on a non-inverted chromosome. The sizes of
perfectly matched sequences is increased due to two misaligned
LCR blocks instead of only one LCR block in chromosome pairing
of non-inverted chromosomes (C) Modeled after Bayes et al.:
Graphic of inter-chromosomal pairing of a normal and an inverted
chromosome by producing a loop-formation. Unequal crossing
over among themisaligned blocksB tel andBmid (x)would lead to
the illustrated chromosomewith a fusion of repeats of block Bwith
a subsequent deletion or a reciprocal duplication of WBS region
(modified after [71]).
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dial blocks B (in the human genome the medial LCR
blockB) andC (in the human genome the centromeric
LCR block C). A first duplication of block C (in the
human genome the telomeric LCR block C) arose
further between the first LCR block A and the HIP1
gene which is a single copy gene next telomeric to the
WBS region. This primordial chromosome of the
WBS locus is common with small differences from the
main lineages of non-human homonidae, i.e. gorilla,
orangutan and chimpanzee. In the human genome,
some Alu-mediated transpositions and other intra-
chromosomal rearrangements due to inverted repeats
occurred during the separation from the non-human
homonidae. A first misalignment through Alu-medi-
ated transposition is proposed to have resulted in
duplication of the medial LCR block A and the
telomeric LCRblockB. In addition, it is supposed that
an inversion occurred in this intermediate chromo-
some by an intrachromosomal rearrangement be-
tween inverted repeats. An interchromosomal non-
allelic homologous recombination between an invert-
ed intermediate chromosome and a non-affected
intermediate chromosome could have led to the final
human chromosome of the WBS region [76, 120]
(Fig. 5).
The low copy repeats (LCR) of the WBS region
The WBS deletion locus on 7q11.23 is a region with a
high density of chromosome 7 specific segmental
genomic duplications. In part, these duplications are
either shaped as tandem repetitions or they derived as
duplication from other genomic regions of chromo-
some 7 [96]. In general, chromosome-specific LCRs
appear to be enriched in centromeric- and subtelo-
mere regions [99, 123]. The single copy region ofWBS
is flanked by such segmental duplications (low copy
repeat sequences – LCR), arranged in three LCR-
blocks, namely A, B and C (Fig. 1).
Previously, it has been shown that a significant
representation of Alu repeats is positioned at the
boundaries of these segmental duplications [124].Alu
repeats are repetitive short interspersed nuclear
elements (SINE) of less than 500 base pairs (bp) in
size, containing a recognition site for the restriction
enzyme Alu [125]. Depending on their appearance,
they can be categorized into three different subfami-
lies – AluJ, AluS and AluY [124]. Alu repeats are
suspected to be predisposing regions for homologous
recombination, which result in various genetic ex-
changes, including duplications, deletions, and trans-
locations [126]. The existence of Alu elements at the
junction region of the large duplicated blocks in
7q11.23 indicates thatAlu-mediated genome shuffling
may have contributed to the final generation of these
large segmental duplications [120].
The single copy gene region is located between the
blocks Cmid andBmid and spans a region of ~1.2Mb.
The centromeric and the telomeric LCRblock order is
C>A>B, whereas the transcription direction of the
centromeric complex is in the opposite direction to the
telomeric complex. The medial LCR complex is
composed of the order C>B>A with the same tran-
scription direction as the centromeric block [73, 88, 89,
127] (Figs. 1 and 2). The centromeric, medial and
telomeric copies of the single blocks share a high
similarity at nucleotide sequence level (98–99%) with
a liability to mispairing and unequal crossover leading
to deletions [78, 88]. The single blocks are composed
mainly of truncated copies of genes, coding for
pseudogenes, except for some genes, which are tran-
scriptionally active (Table 1).
Results of genotyping analysis using STS (sequence
tagged site) markers indicate that the number of LCR
blocks flanking the WBS deletion region might be
variable among 5% of WBS-transmitting progenitors
[106, 128]. While three loci of each block are present
in most individuals, it has been shown in some cases
that blockA or block B is present in two or four copies
on one chromosome [88, 128]. The rate of copy
numbers of LCR blocks is up to 4-fold higher inWBS-
transmitting progenitors as compared to the control
population, thus indicating that this may predispose to
the WBS deletion [128].
Genomic region of block A
This block consists of four different pseudogenes:
STAG3, PMS2, GATS and the WBSCR19 fragment.
These genes are mainly segmental duplications of
other regions on chromosome 7 [63, 77, 96]. The
ancestral gene of STAG3 and GATS are located on
chromosome 7q22, the transcriptionally active gene of
PMS2 is positioned on the short arm of chromosome 7
(7p22) [63, 77].
It is suggested that STAG3 is implicated in chromo-
some pairing during meiosis. Several related STAG3
genes have been mapped to chromosome 7, three
truncated copies are part of block A including the
polymorphic STS marker D7S489. The 5 UTR of the
STAG3-related genes are flanked by a JTV1-related
exon (JTV1RE) showing high similarity to the first
exonof the JTV1 gene,which overlaps thePMS2 gene,
transcribed in the opposite direction on chromosome
7p22 [77].
The gene product of PMS2 on chromosome 7p22
functions as aDNAmismatch repair protein and plays
a role in hereditary cancer, i.e. Turcot Syndrome and
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Figure 5. Depiction of the presumed evolutionary development of the humanWBS chromosome. (A)After divergence of the homonidae,
a first inversion between 7q11 and 7q22 occurred next to the formation of block A by a duplication of an ancestral gene (STAG3) in 7q22.
(B)A first duplication of blockC between the blockAand theHIP1 gene (not shown) arosewith the same orientation of blockA. (C) By a
first misalignment through Alu mediated transposition, a duplication between the ancestral blocks A and B, the medial block A and the
telomericB block appeared. (D)An inversionoccurred in this intermediate chromosomeby an intrachromosomal rearrangement between
inverted repeats. (E) An interchromosomal non-allelic homologous recombination (NAHR) between an inverted intermediate
chromosome and a non-inverted intermediate chromosome could have led to the final human chromosome of the WBS region (modified
after Antonell et al. 2005 [111]).
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Lynch syndrome. Fifteen pseudogene loci of PMS2
exist on chromosome 7, none of them is actively
processed. Some of these pseudogene loci are part of
the LCR block A in one copy or in two or three
repetitions [48, 63, 129, 130]. Most likely, the presence
of these truncated copies of STAG3 and PMS2 arose
as a consequence of evolutionary chromosomal re-
modelling [77].
TheGATS related sequences are present in themedial
and telomeric part of block A. A part of these
sequences show a high level of homology to the 5
end of the pseudogenes of GTF2I on LCR block B
(called ERGP for exon-related to GTF2I pseudo-
genes). It is suggested that evolutionaryAlu-mediated
duplication of the block A and B has promoted this
ERGP in the GATS related sequences (the sequence
homology is indicated as the orange part of GTF2IPs
in Fig. 2). The function of the ancestral GATS gene on
chromosome 7q22 still remains unclear [88].
Furthermore, a genetic fragment, which shares high
similarity toWBSCR19 on chromosome 7p13, is part
of blockA in amulticopy locus pattern. The functional
role of WBSCR19 has not been investigated so far,
most of the available information on this gene product
based on in-silico analyses and theoretical protein
models.
The coding geneWBSCR16 is located at the end of the
medial part of block A. This gene encodes an RCC1-
likeG-exchanging factor.A pseudogene of this gene is
localised in the telomeric part of block A, in the
centromeric part no copy of this region can be found
[70] (Fig. 2, Table 1).
Genomic region of block B
The block B consists of three genes: GTF2I,
GTF2IRD2 and NCF1. The transcriptionally active
copy of GTF2I, which encodes for a transcription
factor (member of the transcription factor family
TFII-I), is localised in the medial part of block B. The
gene copies of GTF2I in the centromeric and telo-
meric part are transcribed as truncated proteins [60,
61, 89]. The GTF2IRD2 gene, which is also a member
of the TFII-I family, appears to be fully transcribed in
parallel by the medial and the telomeric copy of block
B, the centromeric copy of GTF2IRD2 is not ex-
pressed, lacking the exons 1 and 2 [66]. A third
member of this gene family is the GTF2IRD1 gene,
which is a single copy locus, located centromeric to the
medial copy of this LCR block.
Genomic alignments of these genes suggest that
GTF2IRD2 is a truncated version of GTF2I, contain-
ing the 5 coding region of GTF2I [131]. GTF2I itself
appears to be an evolutionary local duplication of
GTF2IRD1 [67]. It has been shown that GTF2I
interacts with GTF2IRD1 [131]. Studies on pheno-
typic features in patientswith partial deletions ofWBS
region suggest that GTF2I and GTF2IRD1 have
overlapping function and are involved in the develop-
ment of the cognitive-behavioural profile of WBS,
especially the severe visuospatial construction deficit
and the hypersociability [92, 93, 132]. Immunhisto-
logical staining on brain tissues from WBS patients
revealed a lack of staining for GTF2I in neurons from
the posterior parietal lobe which include parts of the
dorsal parietal visual pathway [133]. A distinct
phenotypic relation of WBS to GTF2IRD2 haploin-
sufficiency has not been explored so far. There are
some hints that GTF2IRD2 is functionally equal to
the other TFII-I family members according to the
sequence similarity and the putative same evolution-
ary origin [66].
NCF1 is one of theNADPH–oxidase components that
plays an important role in immune defence. It has its
ancestral gene in the medial part of block B. The
centromeric and the telomeric part contain gene copies
of NCF1, which are expressed as truncated proteins
with a very short open reading frame (ORF). Homo-
zygous or compound-heterozygous mutations of this
gene cause one form of chronic granulomatous disease,
a rare disorder with multi-organ manifestation due to
an immunodeficiency [89, 134, 135]. Recent findings
suggest a contribution of NCF1 to the development of
hypertension.Patientswithdeletionbreakpointswithin
the NCF1 or GTF2IRD2 genes presented significantly
less hypertension than in WBS patients with deletion
breakpoint in theGTF2I genewith nohemizygousityof
the NCF1 gene. Reduced angiotensin II-mediated
oxidative stress related to the aberrant NADPH
oxidase activity is assumed to account for this correla-
tion [136, 137] (Fig. 2, Table 1).
Genomic region of block C
Four genes are present in the LCR block C: POM121,
NSUN5, TRIM50 and FKBP6. POM121 is one of the
integral membrane components of the nuclear pore
complex, which mediates the transport of macro-
molecules across the nuclear envelope. Recent studies
have demonstrated that POM121 proteins are ex-
pressed from both centromeric and telomeric gene
loci [138].
The ancestral gene ofNSUN5 is located on Bmid, the
copies ofNSUN5 on the other B blocks (NSUN5B and
–C) are transcribed as truncated copies with a shorter
ORF [120]. All three NSUN5 genes are ubiquitously
expressed, but with some tissue specific pattern for the
truncated copies. At the present, the role of the
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NSUN5 gene product in the human organism is
unclear. NSUN5 shows similarity to a 120-kDa pro-
liferation-associated nuclear antigen, amember of the
evolutionary conservedNOL1/Nop2/sun protein fam-
ily, and to other proteins with a RNA methyltransfer-
ase activity [69, 70].
The TRIM50 gene in B mid and its copies on B cen
(TRIM74) and on B tel (TRIM73) are all expressed.
They share five orthologous exons; exon 6 and 7 are
only present in TRIM50 in B mid. The murine Trim50
gene encodes an E3-ubiquitin-ligase and has a puta-
tive role in the ubiquitin-mediated proteasome path-
way [139].
The ancestral gene of FKBP6 is located on Bmid; the
pseudogenes on B cen and B tel are truncated copies
harbouring the first four exons of the ancestral gene
[73, 57]. FKBP6 is a component of the synaptonemal
complex involved in pairing and recombination of
homologous chromosomes during meiosis [57]. It
plays a role in spermatogenesis; male knock out mice
for FKBP6 show azoospermia, whereas in female
knock out mice no apparent abnormalities are detect-
able [140, 141] (Fig. 2, Table 1).
The single copy gene part of the WBS region
To date 22 genes have been mapped within the single
copy region of WBS between the LCR blocks C mid
and B mid. So far, a genotype-phenotype correlation
could be established for only a few genes (Table 1 and
Fig. 2).
FZD9. The FZD9 gene codes for a transmembrane
cell surface receptor, which mediates signalling upon
binding to a family of secreted Wnt (Wnt: composed
of wg gene from drosophila melanogaster and the
murine Int-1 gene) ligands. It results in the alteration
of b-catenin pathway, which is known to be involved in
development, tumorigenesis and stem cell self-renew-
al. Fzd9 knock out mice exhibit some neuroanatom-
ical defects in hippocampus development (high num-
bers of apoptotic cells and reduction in the total
number of granule cells). Functionally, they displayed
a higher seizure predisposition and defects in visuo-
spatial learning tasks [142]. In another study on Fzd9
knock out mice, no developmental/morphologic fea-
tures typical for WBS were observed. The symptoms
of homozygous knock out mice were limited to the
hematopoietic system with a decrease of B cells in the
bone marrow. Individuals with WBS, who display
heterozygous loss of the FZD9 gene, usually do not
develop any abnormalities in the immunologic or
hematopoietic system [143].
BAZ1B. The BAZ1B protein (alias WSTF: Williams
syndrome transcription factor) is a component of
ATP-dependent chromatin remodelling complexes
WINAC (WSTF Including Nucleosome Assembly
Complex); these complexes are required in many
nuclear processes such as replication, transcription
and chromatin maintenance [144–146]. Furthermore,
the WINAC complex interacts with the vitamin D
receptor via ligand-induced transactivation of the
receptor [147]. BAZ1B is expressed differentially in
neural tissue and it is subcellularly localized to
condensed chromatin. Haploinsufficiency of this
gene possibly leads to an increased chromosomal
condensation and an overall impaired transcriptional
activity of cells, leading to diverse abnormalities,
including abnormal vitamin Dmetabolism and hyper-
calcaemia [144–147].
BCL7B. The function of this gene remains unclear. It
shows a high similarity to BCL7A on chromosome 12
and BCL7C on chromosome 8. These genes are
distributed in the cytoplasm and are expressed in early
embryonic development. For BCL7A, a contribution
to the development of non-Hodgkin-lymphoma has
been shown [148].However, for BCL7B and –C such a
role has not been demonstrated [53, 74].
TBL2. This gene was identified as a protein of the b-
transducin family with four putative WD40-domains
[59, 74]. Expression was shown ubiquitously at lower
levels but predominantly with a smaller transcript in
testis, skeletal muscle, heart and some endocrine
tissues [59]. The function of TBL2 is not resolved so
far. There are some references that transducin family
related proteins act as tumour suppressors [149, 150].
MLXIPL. This gene with alias names: CHREBP or
WBSCR14 encodes a basic-helix–loop–helix leucine
zipper (bHLHZip) transcription factor of the Mondo
family and is expressed in multiple tissues [74, 151]. It
binds to a carbohydrate response element in the
promoter of some glucose-regulated and lipogenic
genes and activates their expression [152–154].
VPS37D. The function of VPS37D (alias WBSCR24)
has not been characterised so far. Orthologous genes
of VPS37D are part of the ESCRT-I (endosomal
sorting complex required for transport). This protein
complex functions in recognition and sorting of
ubiquitinated transmembrane proteins into multive-
sicular body vesicles. In human, four homologous
proteins (VPS37A-D) have been identified [155–
157].
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DNAJC30. DNAJC30 (WBSCR18) is a member of
the DNAJ molecular chaperone homology domain-
containing protein family [70]. This is a super family of
heat shock proteins (HSPs), known to stimulate the
ATPase domain of HSPA chaperones. In the human
genome, at least 41 different DNAJ-encoding genes
have been identified; the cellular functions are
currently unknown for most of its members [158].
WBSCR22. The putative protein of the WBSCR22
gene contains an S-adenosyl-L-methionine binding
motif typical of methyltransferases. Expression was
detected ubiquitously with a strong signal in testis [69,
70].
STX1A. STX1A plays an essential role in exocytosis
of neuronal and neuroendocrine cells; it is also related
to neurotransmitter release and vesicle fusion proc-
esses. Furthermore, it is suggested that STX1A
directly modulates ion channels in exocrine and
muscular cells [47, 159–162]. Both Stx1a knock out
– and Stx1a transgenic mice display a reduced insulin
release and an impaired glucose homeostasis, possibly
via an aberrant regulation of pancreatic b-cell ion
channels. The genetic alteration of STX1A levels
might also contribute to impaired glucosemetabolism,
which occurs with increased incidence in adults with
WBS [23, 163, 164]. In cognitive functional test, Stx1a
knock out mice demonstrated an increased condi-
tioned fear memory lacking any other difference in
appearance compared with control littermate [165].
ABHD11. ABHD11 (WBSCR21) contains an a-b-
hydrolase domain. It is spliced in different transcripts;
some of them are truncated. The gene is expressed
ubiquitously, the biological function has not been
determined so far [70].
CLDN3 and CLDN4. The claudin (CLDN) genes
encode a family of proteins involved in the formation
and function of tight junctions, and they are implicated
in regulating the permeability of the paracellular
pathway. The expression of the CLDN genes is
frequently altered in several human cancers [166–
168].
WBSCR27 and WBSCR28. The function of these
genes remains unclear. Recently, in a study of genes
which are involved in the development of prostate
cancer,WBSCR28 was repressed by androgen recep-
tor activity [169].
ELN.The elastin gene is the best-explored gene of the
WBS region and it has been demonstrated that
haploinsufficiency as well as heterozygous point
mutations cause SVAS [29–34, 170]. Heterozygous
knock out mice of the Eln gene display high blood
pressure, constriction of arteries and rigid arterial
walls [170].
LIMK1. This gene belongs to a protein kinase family
involved in brain development. It has been shown in-
vivo that LIMK1 is localized at the neuromuscular
synapse, suggesting that LIMK1 may play a role in
synapse formation and maintenance [171]. A striking
feature in children with WBS is the disability of
reproduction of visually obtained objects (impaired
visuospatial constructive cognition), LIMK1 is sus-
pected to contribute to this characteristic. This
assumption is based on reports of children, affected
by an isolated SVAS and a visuospatial impairment,
with a partial deletion of the WBS region comprising
only the genesELN andLIMK1 [43, 172]. In contrast
to these facts, other reports on individuals with partial
deletion of theWBS region encompassing theLIMK1
region do not display weakness in spatial cognition
[44, 173]. Limk1 knock out mice display insufficiency
in re-learning spatial information. Furthermore, they
show abnormalities in synaptic structure and dendritic
spine development, most likely due to aberrant
quantitative and structural regulation of the actin
cytoskeleton [174]. In summary, these data support
the assumption that LIMK1 contributes in larger scale
to brain morphology (i.e. synaptic structure and
–plasticity) and cognitive function (i.e. impaired
spatial cognition and abnormal motor activity). How-
ever, it remains unclear if these abnormalities in
dendritic spine morphology are also present in WBS
patients and contribute to the morphological and
behavioural abnormalities observed.
EIF4H. This gene is ubiquitously expressed and it is
suggested that it is involved in translation initiation
and in stabilizing attributes duringRNAbinding,ATP
hydrolysis and RNA duplex unwinding [175].
LAT2. LAT2 is a transmembrane adaptor in specific
cell types of hematopoietic lineages. Functional
studies have indicated that LAT2 plays a putative
role as regulator of mast cell activation, but its defined
role in the organism remains unclear [176].
RFC2. RFC2 is a subunit of the replication factor C
complex that, together with the proliferating-cell
nuclear antigen (PCNA), is required for elongation
of primedDNA templates [45].When bound toDNA,
this complex organizes various proteins involved in
DNA replication, DNA repair, DNA modification
and chromatin modelling [177].
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CLIP2. CLIP2 (alias CYLN2) belongs to a family of
membrane–microtubule interacting proteins that is
highly enriched in neurons of the hippocampus,
piriform cortex, olfactory bulb, and inferior olive
[56]. Clip2 knock out mice show both morphological
brain abnormalities and behavioural abnormalities
that can be attributed to deficits in cerebellar and
hippocampal functioning [178]. Furthermore, there
are several reports of partial deletions of the WBS
region not including the CLIP2 gene. The clinical
findings in this collective suggest a major role for
CLIP2 in the motor and cognitive characteristics of
WBS. These patients with a partial deletion excluding,
amongst others, the CLIP2 gene displayed only a mild
or no visual-spatial impairment and they performed
better on tasks testing perception, fine motor coordi-
nation and gross motor skills [178, 179].
GTF2IRD1.GTF2IRD1 belongs, togetherwithGTF2I
andGTF2IRD2 (located in LCR blockB), to the TFII-
I transcription factor family, the gene products are
involved in transcriptional regulation, signal trans-
duction, immune response and chromatin remodelling.
Functional studies on GTF2IRD1 in different species
have shown that it binds to a number of regulatory
elements upstream of genes, which are involved in
tissue development and differentiation [180]. Expres-
sion of Gtf2ird1 during mouse development is found
predominantly in musculoskeletal tissues, the pituitary,
craniofacial tissues, the eyes and tooth buds [181]. In
addition, the TFII-I gene family shows high expression
during murine odontogenesis, expression of Gtf2ird1
and Gtf2ird2 was observed in preameloblasts and
preodontoblasts. So maybe, haploinsufficiency of
these genes is causative for tooth abnormalities in
WBS [182, 183]. Homozygous knock out mice of
Gtf2ird1 display further craniofacial abnormalities
including periorbital fullness and a short snout related
to those craniofacial dysmorphisms seen in WBS. This
is consistent with the expression pattern of Gtf2ird1 in
the development of the brain and craniofacial areas.
Furthermore, this conclusion is supported by the
function of GTF2IRD1 to regulate expression of
genes, which are involved in craniofacial and skeletal
development [184]. Furthermore, mutant mice reveal
reduced fear and aggression and increased social
behaviour, which would be in accord with the typical
findings of hypersociability in WBS. Biochemical
analyses showed an increased serotonin metabolism
in several brain regions [185]. However, in another
study on Gtf2ird1 knock out mice no morphological
abnormalities of the brain (except of increased ven-
tricle volume) and in hippocampal and cerebellar
functioning (i.e. fear conditioning and motor coordina-
tion tests) were observed in the mice mutants [179].
WBSCR23.WBSCR23 is a putative intronless gene of
~ 800 bp mapped to intron 9 of the GTF2IRD1 gene
with the sameorientation asGTF2IRD1.The function
of this transcript remains still unclear.
Expression level of genes within the WBS region
There are some studies that have investigated the
expression level of WBS genes in different genomic
rearrangements of the WBS region. In a collection of
WBS patients with a common deletion size, the
expression of genes located within the WBS region
(includingLCRblocks) and somegenes locatedoutside
the WBS region was studied by quantitative real time
PCR. With the exception of two genes (ELN and
GTF2IRD1), hemizygously deleted genes within the
WBS region showed significantly reduced expression
levels that were approximately 50% of the wild type
levels. The origin of the aberrant expression level of
ELN and GTF2IRD1 could not be studied in more
detail due to restricted sample number and suspected
tissue specific expression pattern of both genes. In
addition, a remarkable decrease in relative expression
was also detected in non-hemizygous genes outside the
WBS deletion region (ASL, KCTD7, HIP1, POR,
MDH2), though the expression decrease was not as
large as that observed for hemizygous genes. These
findings suggest that genes that map close to the
deletion region may be regulated by genes located
within theWBS region via cis-regulatory elements and
are jointly responsible for features of WBS phenotype
[186].
An altered expression of genes within theWBS region
was also found in patients with duplications in this
region. Gene-expression analysis forGTF2I, LIMK1,
EIF4H, RFC2, BAZ1B and LAT2 revealed an in-
creased expression for all tested genes except of
LAT2. The expression of LAT2 showed normal level
that was consistent with levels in controls. In persons
with a WBS, the expression level of LAT2 is reduced.
For WBSCR16 located outside to the telomeric
breakpoint no altered expression was seen [112].
In individuals carrying an inversion ofWBS region, no
significant differences in gene expression were found
compared to a collection without the inversion [108].
Genotype-Phenotype correlation in WBS
The WBS deletion region encompasses to date 28
transcribed genes. The design of a genotype-phenotype
correlation inpatientswithWBS isdifficult due to some
special patterns concerning theWBS region. Currently,
data of altered expression and haploinsufficiency in
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affectedgenes areonlyavailableona restrictednumber
of loci. Furthermore, the benefit from knock out mice
concerning mental and behavioural aspects in WBS is
limited, especially for the development of the cognitive
features inWBS, inwhich a co-action of several genes is
proposed. The minimal critical interval that causes the
typical phenotype in individuals withWBS is estimated
to span the region between the ELN gene and the
common telomeric breakpoint [112, 127]. Undoubted-
ly, haploinsufficiency of the ELN gene causes SVAS
and other cardiovascular manifestations; further, it
might contribute to connective tissue weakness (i.e.
inguinal hernia) [187]. For the occurrence of the
behavioural and the cognitive aspects in WBS patients
(mental retardation, visual spatial impairment, over-
friendliness and strength in verbal skills), several genes
telomeric to the ELN gene are suspected of being
responsible. Based on results from knock out mice
studies, from in vitro assays on gene expression and
from clinical findings in patients with only partial
deletions of theWBS region, the genesLIMK1, CLIP2
(alias CYLN2) and the two members of TFII-I tran-
scription family (GTF2IRD1andGTF2I)are identified
as playing the major role in developing the cognitive
features [12, 43, 93–95, 179, 186, 188]. Furthermore
there are some hints that haploinsufficiency of BAZ1B
may contribute to the hypercalcaemia in infants with
WBS [147].
Diagnosis and genetic counselling in WBS
The diagnosis of WBS should be considered if typical
symptoms such as SVAS together with mental retarda-
tion and other typical behavioural features occur in a
patient. FISH analysis can be performed to confirm
diagnosis. The FISH- and/ormicrosatellite analyses are
the most widespread analysis strategies for deletion
detection in WBS patients [40]. These analyses are
useful tools for routine diagnosis of WBS and allow an
approximate estimation of the deletion size. To estab-
lish a phenotype/genotype correlation and for predic-
tion of disease-course and development depending on
the number of deleted genes, a quantitative assay for
diagnosis is more appropriate. The quantitative real-
timePCR(qPCR)orMLPAassay (multiplex ligation-
dependent probe amplification) are currently the most
usefulmethods [189, 190].With the quantitative assays,
a high resolution of the deletion size is possible as
compared to conventional techniques, i.e. FISH or
microsatellite investigations. Moreover, informative
STS markers and parental DNA for microsatellite
analysis are not necessary. Furthermore, qPCR allows
subsequent analysis of the sub regions of microdele-
tions and allows refining the deletion breakpoints. At
present, the quantitative determination of deletion size
is restricted to research applications, since the clinical
benefit is limited by the lack of strong correlation
between deletion size and phenotype. One exception
may be the NCF1 gene, where, in the case of non-
hemizygousity, the development of hypertension is
more likely [136]. Furthermore, the detection of much
larger deletions expanding the commondeletion size of
the region may have significant prognostic value, since
these patients seem to suffer from amore severe course
of disease and often present with seizure [68, 191–194].
Usually, WBS occurs sporadically with only a slight
increased risk in the range of 1–2% of recurrences for
siblings of affected children. Nevertheless, the possi-
bility of a gonadal mosaicism for the deletion has to be
considered [79, 80]. Inversion carriers at 7q11.23 will
have an increased risk of meiotic recombination
leading to gametes with unbalanced rearrangements.
In the chromosomal region of WBS, a recombination
rate of 0.3–1% approximately matches to the genome
average of 1 Mb. Therefore, the frequency of recombi-
nation in the misaligned non-inverted fragments (~100
kb) would be 0.03–0.1%, leading to a deletion and or
duplication [103, 106]. In addition, in case of a para-
centric inversion the formation of either one or two
chromosomal loops can arise. If recombination occurs
within the loops it would lead to either an acentric or
dicentric chromosome 7, which would be associated
with an increased risk for abortion in families carrying
the inversion polymorphism. For carriers of either two
or four flanking LCR blocks as a replacement for the
normal three LCR copies (5% of the WBS-transmit-
ting progenitors) a further predisposition for unequal
chromosomal misalignment exists [78, 106, 128].
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